These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12348219

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O.
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [Abstract] [Full Text] [Related]

  • 23. Third-generation OCs safe, health officials say.
    Contracept Technol Update; 1999 Dec; 20(12):140-1. PubMed ID: 12295559
    [Abstract] [Full Text] [Related]

  • 24. Third-generation oral contraceptives: how risky?
    Weiss N.
    Lancet; 1995 Dec 16; 346(8990):1570. PubMed ID: 7500743
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
    Spitzer WO.
    Am J Obstet Gynecol; 1998 Sep 16; 179(3 Pt 2):S43-50. PubMed ID: 9753310
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Third generation progestagens].
    Belaisch J, Eliakim V.
    Contracept Fertil Sex (Paris); 1993 Apr 16; 21(4):287-93. PubMed ID: 12318226
    [Abstract] [Full Text] [Related]

  • 29. The 1995 pill scare revisited: anatomy of a non-epidemic.
    Spitzer WO.
    Hum Reprod; 1997 Nov 16; 12(11):2347-57. PubMed ID: 9436662
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Coagulation and thrombosis with OC use: physiology and clinical relevance.
    Comp PC.
    Dialogues Contracept; 1996 Nov 16; 5(1):1-3. PubMed ID: 12347721
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Oral contraception and circulatory risks].
    Wingrave SJ.
    Contracept Fertil Sex (Paris); 1984 Oct 16; 12(10):1111-6. PubMed ID: 12266560
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
    Spitzer WO.
    Br J Clin Pharmacol; 1996 May 16; 41(5):359-63. PubMed ID: 8735675
    [Abstract] [Full Text] [Related]

  • 38. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D, Wildemeersch D, Verougstraete A, Creatsas G.
    Int J Fertil Menopausal Stud; 1995 May 16; 40 Suppl 2():73-9. PubMed ID: 8574253
    [Abstract] [Full Text] [Related]

  • 39. Venous thromboembolism among new users of different oral contraceptives.
    Herings RM, Urquhart J, Leufkens HG.
    Lancet; 1999 Jul 10; 354(9173):127-8. PubMed ID: 10408492
    [Abstract] [Full Text] [Related]

  • 40. Oral contraception scare has reduced confidence in medical services.
    Notter J.
    Br J Nurs; 1999 Jul 10; 4(20):1174, 1176. PubMed ID: 8696083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.